JOHNSON & JOHNSON·4

Jul 18, 4:12 PM ET

REED JOHN C 4

4 · JOHNSON & JOHNSON · Filed Jul 18, 2025

Insider Transaction Report

Form 4
Period: 2025-07-17
REED JOHN C
EVP, Innovative Medicine, R&D
Transactions
  • Sale

    Common Stock

    2025-07-17$163.55/sh19,137$3,129,83010,658 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $163.52 to $163.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    wk-form4_1752869553.xmlPrimary

    FORM 4